DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20204562

A study on efficacy of high fluence Q-switched neodymium doped yttrium aluminium garnet laser in macular amyloidosis

Jasleen Kaur, Tanreet Kaur

Abstract


Background: Macular amyloidosis (MA) typically presents as small, dusky-brown or greyish pigmented macules, treatment of which remains challenging with topical and systemic therapies, however Q-switched neodymium-doped yttrium aluminium garnet (Nd:YAG) laser has proven to be an effective treatment modality to reduce hyperpigmentation. The aim of the study is to study the efficacy of Nd:YAG laser in the management of MA.

Methods: 30 female patients were treated with Q-switched Nd:YAG laser at 1064 nm with a spot size of 3 mm at a fluence of 6-7 J/cm2, frequency of 2 Hz, for 350-500 pulses. Total number of pulses decreased with each treatment session as the intensity of the hyperpigmentation decreased. The procedure was repeated at one-month intervals for a total of 6 treatment sessions.

Results: After completion of treatment sessions with Nd-YAG laser 36.66% patients showed >50% improvement in the pigmentation. 66.6% patients were satisfied with the laser treatment. 33.3% patients showed <25% improvement and unsatisfied with the treatment.

Conclusion: MA remains an enigma and a source of concern for the suffering patients and physicians. Q-switched Nd-YAG laser 1064 nm has shown positive response in the reduction of pigmentation in MA.


Keywords


Nd:YAG laser, Macular amyloidosis, Hyperpigmentation

Full Text:

PDF

References


Kumar P, Neema S, Pathak N. Macular amyloidosis in a middle-aged woman. Pigment Int. 2018;5:57-8.

Vijaya B, Dalal BS, Manjunath GV. Primary cutaneous amyloidosis: A clinico-pathological study with emphasis on polarized microscopy. Indian J Pathol Microbiol. 2012;55:17.

Eswaramoorthy V, Kaur I, Das A, Kumar B. Macular amyloidosis: Etiological factors. J Dermatol. 1999;26:305-10.

Chuang YY, Lee DD, Lin CS, Chang YJ, Tanaka M, Chang YT et al. Characteristic dermoscopic features of primary cutaneous amyloidosis: A study of 35 cases. Br J Dermatol. 2012;167:548-54.

Khurana N, Urman C. The Efficacy of Q-Switched ND:YAG 1064 nm Laser in Recalcitrant Macular Amyloidosis: A Case Report. J Drugs Dermatol. 2016;15(11):1456-58.

Neema S, Jha A. Lichen planus pigmentosus. Pigment Int. 2017;4:48-9.

Aurangabadkar SJ. Optimizing Q-switched lasers for melasma and acquired dermal melanoses. Indian J Dermatol Venereol Leprol. 2019;85:10-7.

Arsiwala SZ, Majid IM. Methods to overcome poor responses and challenges of laser hair removal in dark skin. Indian J Dermatol Venereol Leprol. 2019;85:3-9.

Ostovari N, Mohtasham N, Oadras MS, Malekzad F. 532-nm and 1064-nm Q-switched Nd:YAG laser therapy for reduction of pigmentation in macular amyloidosis patches. J Eur Acad Dermatol Venereol. 22:442-6.

Bandhlish A, Aggarwal A, Koranne RV. A clinico-epidemiological study of macular amyloidosis from north India. Indian J Dermatol. 2012;57(4):269-74.

Rasi A, Khatami A, Javaheri SM. Macular amyloidosis: An assessment of prevalence, sex, and age. Int J Dermatol. 2004;43:898-9.

Ratrout JT, Satti MB. Primary localized cutaneous amyloidosis: A clinicopathologic study from Saudi Arabia. Int J Dermatol. 1997;36:428-34.

Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS, et al. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol. 1989;93:28-32.

Al Yahya RS. Treatment of primary cutaneous amyloidosis with laser: a review of the literature. Lasers Med Sci. 2016;31(5):1027-35.

Barsky M, Buka RL. Pulsed dye laser for the treatment of macular amyloidosis: a case report. Cutis. 2014;93(4):189-92.

Esmat SM, Fawzi MM, Gawdat HI, Ali HS, Sayed SS. Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis: a randomized clinical trial. Lasers Surg Med. 2015;47:388-95.